{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:49:48Z","timestamp":1782805788778,"version":"3.54.5"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatocellular carcinoma (HCC) is one of the most common types of cancers and a global health challenge with a low early diagnosis rate and high mortality. The coagulation cascade plays an important role in the tumor immune microenvironment (TME) of HCC. In this study, based on the coagulation pathways collected from the KEGG database, two coagulation-related subtypes were distinguished in HCC patients. We demonstrated the distinct differences in immune characteristics and prognostic stratification between two coagulation-related subtypes. A coagulation-related risk score prognostic model was developed in the Cancer Genome Atlas (TCGA) cohort for risk stratification and prognosis prediction. The predictive values of the coagulation-related risk score in prognosis and immunotherapy were also verified in the TCGA and International Cancer Genome Consortium cohorts. A nomogram was also established to facilitate the clinical use of this risk score and verified its effectiveness using different approaches. Based on these results, we can conclude that there is an obvious correlation between the coagulation and the TME in HCC, and the risk score could serve as a robust prognostic biomarker, provide therapeutic benefits for chemotherapy and immunotherapy and may be helpful for clinical decision making in HCC patients.<\/jats:p>","DOI":"10.1093\/bib\/bbac291","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T14:21:13Z","timestamp":1658154073000},"source":"Crossref","is-referenced-by-count":82,"title":["Immune infiltration and clinical significance analyses of the coagulation-related genes in hepatocellular carcinoma"],"prefix":"10.1093","volume":"23","author":[{"given":"Qifan","family":"He","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Soochow University , Suzhou 215006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Soochow University , Suzhou 215006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-1951","authenticated-orcid":false,"given":"Yonghai","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Soochow University , Suzhou 215006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"key":"2022071906210432600_ref1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"New Engl J Med"},{"key":"2022071906210432600_ref2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.21147\/j.issn.1000-9604.2018.06.01","article-title":"Liver cancer incidence and mortality in China: temporal trends and projections to 2030","volume":"30","author":"Zheng","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"2022071906210432600_ref3","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1245\/s10434-018-6671-7","article-title":"Venous thromboembolic events following major pelvic and abdominal surgeries for cancer: a prospective cohort study","volume":"25","author":"Serrano","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2022071906210432600_ref4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.thromres.2007.10.009","article-title":"Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma","volume":"122","author":"Connolly","year":"2008","journal-title":"Thromb Res"},{"key":"2022071906210432600_ref5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0039-1687908","article-title":"Tumors: wounds that do not heal-a historical perspective with a focus on the fundamental roles of increased vascular permeability and clotting","volume":"45","author":"Dvorak","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"2022071906210432600_ref6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1023\/B:DDAS.0000030099.13397.28","article-title":"Hypercoagulable states in patients with hepatocellular carcinoma","volume":"49","author":"Samonakis","year":"2004","journal-title":"Dig Dis Sci"},{"key":"2022071906210432600_ref7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s004320050189","article-title":"Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study","volume":"124","author":"Pirisi","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"2022071906210432600_ref8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00262-020-02739-w","article-title":"A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment","volume":"70","author":"Saidak","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"2022071906210432600_ref9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115801","article-title":"Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: a review","volume":"22","author":"Oura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2022071906210432600_ref10","doi-asserted-by":"crossref","first-page":"10643","DOI":"10.1158\/0008-5472.CAN-06-2350","article-title":"Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans","volume":"66","author":"Rak","year":"2006","journal-title":"Cancer Res"},{"key":"2022071906210432600_ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.trecan.2021.12.008","article-title":"Coagulome and the tumor microenvironment: an actionable interplay","volume":"8","author":"Galmiche","year":"2022","journal-title":"Trends Cancer"},{"key":"2022071906210432600_ref12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","article-title":"The coagulation and immune systems are directly linked through the activation of interleukin-1\u03b1 by thrombin","volume":"50","author":"Burzynski","year":"2019","journal-title":"Immunity"},{"key":"2022071906210432600_ref13","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205103","article-title":"Anticoagulation with factor Xa inhibitors is associated with improved overall response and progression-free survival in patients with metastatic malignant melanoma receiving immune checkpoint inhibitors-a retrospective, real-world cohort study","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2022071906210432600_ref14","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2022071906210432600_ref15","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"2022071906210432600_ref16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","article-title":"The international cancer genome consortium data portal","volume":"37","author":"Zhang","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2022071906210432600_ref17","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/annonc\/mdx518","article-title":"Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: post-progression outcomes from the phase II IMvigor210 study","volume":"28","author":"Necchi","year":"2017","journal-title":"Ann Oncol"},{"key":"2022071906210432600_ref18","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenviro-nment evolution during immunotherapy with Nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2022071906210432600_ref19","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2022071906210432600_ref20","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"2022071906210432600_ref21","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"2022071906210432600_ref22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"2022071906210432600_ref23","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"Bmc Bioinformatics"},{"key":"2022071906210432600_ref24","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022071906210432600_ref25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2022071906210432600_ref26","doi-asserted-by":"crossref","first-page":"1902880","DOI":"10.1002\/advs.201902880","article-title":"ImmuCellAI: a unique method for comprehensive T-cell subsets abundance prediction and its application in cancer immunotherapy","volume":"7","author":"Miao","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"2022071906210432600_ref27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"2022071906210432600_ref28","doi-asserted-by":"crossref","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"2022071906210432600_ref29","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2022071906210432600_ref30","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2022071906210432600_ref31","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"2022071906210432600_ref32","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"2022071906210432600_ref33","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"2022071906210432600_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"2022071906210432600_ref35","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S plus to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"Bmc Bioinformatics"},{"key":"2022071906210432600_ref36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic analyses reveal genotype-Immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"2022071906210432600_ref37","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"2022071906210432600_ref38","doi-asserted-by":"crossref","first-page":"e002467","DOI":"10.1136\/jitc-2021-002467","article-title":"Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer","volume":"9","author":"Zeng","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2022071906210432600_ref39","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2022071906210432600_ref40","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2022071906210432600_ref41","doi-asserted-by":"crossref","first-page":"869993","DOI":"10.3389\/fimmu.2022.869993","article-title":"Development and validation of TACE refractoriness-related diagnostic and prognostic scores and characterization of tumor microenvironment infiltration in hepatocellular carcinoma","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"2022071906210432600_ref42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"key":"2022071906210432600_ref43","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"2022071906210432600_ref44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-20315-3_2","article-title":"Pathophysiology 1. Mechanisms of thrombosis in cancer patients","volume":"179","author":"Falanga","year":"2019","journal-title":"Cancer Treat Res"},{"key":"2022071906210432600_ref45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"2022071906210432600_ref46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"2022071906210432600_ref47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004836-200001000-00013","article-title":"The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis","volume":"30","author":"Egesel","year":"2000","journal-title":"J Clin Gastroenterol"},{"key":"2022071906210432600_ref48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.46.4.534","article-title":"Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?","volume":"46","author":"Fisher","year":"2000","journal-title":"Gut"},{"key":"2022071906210432600_ref49","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3748\/wjg.v22.i1.407","article-title":"Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: a comprehensive review","volume":"22","author":"Han","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2022071906210432600_ref50","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s004320100237","article-title":"The potential of plasma thrombomodulin as a biomarker of portal vein tumor thrombus in hepatocellular carcinoma","volume":"127","author":"Zhou","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"2022071906210432600_ref51","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3748\/wjg.v27.i22.2994","article-title":"Hepatocellular carcinoma in viral and autoimmune liver diseases: role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment","volume":"27","author":"Granito","year":"2021","journal-title":"World J Gastroenterol"},{"key":"2022071906210432600_ref52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fonc.2019.00421","article-title":"Macrophage polarization in the development and progression of ovarian cancers: an overview","volume":"9","author":"Cheng","year":"2019","journal-title":"Front Oncol"},{"key":"2022071906210432600_ref53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"2022071906210432600_ref54","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022071906210432600_ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2016.10.014","article-title":"Function of follicular helper T cell is impaired and correlates with survival time in non-small cell lung cancer","volume":"41","author":"Ma","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"2022071906210432600_ref56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8(+) T cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol"},{"key":"2022071906210432600_ref57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40659-018-0202-7","article-title":"Overexpression of PIK3R1 promotes hepatocellular carcinoma progression","volume":"51","author":"Ai","year":"2018","journal-title":"Biol Res"},{"key":"2022071906210432600_ref58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.csbj.2019.03.006","article-title":"Application of PD-1 blockade in cancer immunotherapy","volume":"17","author":"Wu","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"2022071906210432600_ref59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/4\/bbac291\/45016648\/bbac291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/4\/bbac291\/45016648\/bbac291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T06:25:07Z","timestamp":1658211907000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbac291\/6645203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbac291","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,18]]},"published":{"date-parts":[[2022,7,16]]},"article-number":"bbac291"}}